Pantoprazole Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 20 mg, 40 mg
Reference Brands: Protonix(US & EU)
Category:
Medical Aid
Pantoprazole tablets work by irreversibly inhibiting the gastric H⁺/K⁺ ATPase enzyme, reducing stomach acid production. Benefits include relief from GERD, ulcers, and acid reflux, promoting mucosal healing, reducing discomfort, and preventing acid-related damage, thereby improving quality of life and preventing complications associated with excessive stomach acid.
Pantoprazole tablets is available in Tablet
and strengths such as 20 mg, 40 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Pantoprazole tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Pantoprazole tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Pantoprazole tablets are approved in both the US and EU, supported by comprehensive dossiers demonstrating safety, efficacy, and strict GMP compliance. In the US, Protonix is a leading branded product, while in the EU, generic and branded versions like Pantoloc are available. Regulatory approval involves rigorous clinical evaluation and documentation of quality standards. These products are widely used for GERD, ulcers, and acid-related disorders. For detailed information on licensing, approved dossiers, and regulatory requirements for pantoprazole tablets, visit Pharmatradz. Stay informed on the latest updates and licensing processes for pantoprazole in global markets.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing